baber/WOPTO huggingface dataset:
Patent AU-2019216589-B2 (AU)
Title: Wake-up system and method for powered surgical instruments
Inventor: LECH RICHARD
IPC: A61B17/00
Filed: 2019-08-12
Granted: 2020-09-03
Abstract: WAKE-UP SYSTEM AND METHOD FOR POWERED SURGICAL 
INSTRUMENTS 
ABSTRACT 
The present disclosure is directed to an electromechanical surgical system having an end 
effector and an adapter assembly (14) for selectively interconnecting the end effector and a hand
held surgical instrument (10). A one-wire bidirectional serial communications interface or bus 
(36) extends through the end effector, the adapter assembly (14), and the hand-held surgical 
instrument (10). The hand-held surgical instrument (10) includes a master circuit (34) coupled to 
the bus (36) and configured to identify or control the adapter assembly (14) or the end effector.  
A power source (44) is couplable to the bus (36) and configured to provide power to the adapter 
assembly (14) or the end effector. A first switch connects the master circuit (34) to the bus (36) 
and a second switch connects the power source (44) to the bus (36). A processor (32) controls 
operation of the hand-held surgical instrument (10). The controller (30) has a wake-up pin (40) 
connected to the bus (36) and is configured to receive a presence pulse from the adapter (14) or 
end effector.
Patent AU-2019247891-B2 (AU)
Title: Synthetic fiber with addition of natural material and method of its production
Inventor: JAŠŠ BRANKO
IPC: D01F1/10
Filed: 2019-04-04
Granted: 2023-09-14
Abstract: The volume content of the natural material in the resulting volume of the synthetic fiber (1) ranges from 0,5% to 45%. The natural material is milled into the form of particles (2) which have irregular shape with length differing from the width, whereby length (L) of the particle (2) of the natural material has a value ranging from 10% to 120% of the diameter of the synthetic fiber (1) and the width (W) of the particle ranges from 25% to 75 % of the length (L) of the particle (2). At the same time the width (W) of the particle (2) does not surpass 50% of the cross-sectional diameter (D) of the synthetic fiber (1). Hemp, jute, linen, cotton, sisal, kenaf, wood, cellulose, lignocellulose, coconut, nut shells, starch, wheat, zeolite can be used as a natural material. The basic synthetic polymer component includes at least one thermoplastic polymer, for example polyolefin, such as polyethylene PE or polypropylene PP. Before the fiberization the natural material in form of milled particles (2) is added into the melt and subsequently the mixture of the synthetic polymer and particles (2) of the natural material are mixed at least for 5 minutes.
Patent AU-2019260382-B2 (AU)
Title: Feeding arrangement for a granulator and granulator comprising such a feeding arrangement
Inventor: SJÖBERG KURT
IPC: B29B9/04
Filed: 2019-04-02
Granted: 2021-03-04
Abstract: Disclosed is an accumulation device (150) operable in a feeding arrangement (110) of a granulator, for accumulating substantially flat material to be granulated. The accumulation device (150) comprises a first guiding device (152) and a second guiding device (154). The accumulation device (150) further comprises a rotational shaft (156) arranged to connect the accumulation device (150) to the feeding arrangement (110). The first and the second guiding device (152, 154) are fixedly arranged in relation to each other so that when the accumulation device (150) is rotated around its rotational shaft, the first guiding device (152) as well as the second guiding device (154) is rotated around the rotational shaft (156). Disclosed are further a feeding arrangement (110) and a granulator comprising such an accumulator device (150).
Patent AU-2019304104-B2 (AU)
Title: A quantum processing system
Inventor: VOISIN BENOIT
IPC: G06N10/00
Filed: 2019-07-19
Granted: 2023-03-09
Abstract: A quantum processing system is disclosed. In one embodiment, a quantum processing system comprises: a plurality of donor atoms positioned in a silicon crystal substrate, each donor atom positioned at a donor site; and a plurality of conductive control electrodes arranged about the donor atoms to operate the donor atoms as qubits. Where, at least two pairs of nearest neighbour donor atoms of the plurality of donor atoms are arranged along the [110] direction of the silicon crystal substrate and are configured to operate as qubits.
Patent AU-2019326304-B2 (AU)
Title: Switched reluctance motor control system
Inventor: KHALIL AHMED
IPC: H02P6/18
Filed: 2019-08-12
Granted: 2022-09-15
Abstract: A device may receive a current measurement of a motor identifying a plurality of component currents associated with a plurality of phases. The device may determine a position estimate for the motor based on the plurality of component currents associated with the plurality of phases. The device may control the motor based on the plurality of component currents.
Patent AU-2019374104-B2 (AU)
Title: Additives for geopolymer cements
Inventor: KINNEY FREDERICK D
IPC: C04B22/06
Filed: 2019-11-01
Granted: 2021-10-21
Abstract: The present disclosure is directed to chemical additives for geopolymer cements that can improve the rheological properties of geopolymer cements. These chemical additives include sulfates and selenates of a specific formula as well as hydroxycarboxylic acid salts of Li, Na, and K including but not limited to glycolic, lactic, citric, mandelic tartaric, and malic acids. The chemical additives for geopolymer cements disclosed herein can facilitate the uniform mixing, increase the time mixtures can be transported, and improve the ability to place and finish concrete and mortars made with the geopolymer cements.
Patent AU-2020224067-B2 (AU)
Title: Providing services with guest VM mobility
Inventor: MISHRA RAHUL
IPC: G06F9/50
Filed: 2020-02-03
Granted: 2023-07-06
Abstract: Some embodiments provide novel methods for performing services for machines operating in one or more datacenters. For instance, for a group of related guest machines (e.g., a group of tenant machines), some embodiments define two different forwarding planes: (1) a guest forwarding plane and (2) a service forwarding plane. The guest forwarding plane connects to the machines in the group and performs L2 and/or L3 forwarding for these machines. The service forwarding plane (1) connects to the service nodes that perform services on data messages sent to and from these machines, and (2) forwards these data messages to the service nodes. In some embodiments, the guest machines do not connect directly with the service forwarding plane. For instance, in some embodiments, each forwarding plane connects to a machine or service node through a port that receives data messages from, or supplies data messages to, the machine or service node. In such embodiments, the service forwarding plane does not have a port that directly receives data messages from, or supplies data messages to, any guest machine Instead, in some such embodiments, data associated with a guest machine is routed to a port proxy module executing on the same host computer, and this other module has a service plane port. This port proxy module in some embodiments indirectly can connect more than one guest machine on the same host to the service plane (i.e., can serve as the port proxy module for more than one guest machine on the same host).
Patent AU-2020227042-B2 (AU)
Title: Single vial vaccine formulations
Inventor: FOX CHRISTOPHER B
IPC: A61K39/085
Filed: 2020-09-02
Granted: 2021-12-02
Abstract: The invention provides for thermostable lyophilized formulations, including vaccines and 
pharmaceutical compositions for inducing or enhancing an immune response, and methods of 
use thereof. The lyophilized formulations generally comprise an antigen and/or an adjuvant, a 
metabolizable oil, and a cake-forming excipient.
Patent AU-2020233773-B2 (AU)
Title: Stilbene derivative and method for preparing same
Inventor: LEE MIN-KYUNG
IPC: C07D241/04
Filed: 2020-09-18
Granted: 2022-07-07
Abstract: This invention relates to a stilbene derivative and a method of preparing the same, 
and more particularly to a novel stilbene derivative for inhibiting the function of 
cyclophilin, which is effective at the prevention of cyclophilin-related diseases or at the 
treatment of symptoms of such diseases, and to a method of preparing the same.
Patent AU-2020239799-B2 (AU)
Title: Real-time cathodic protection integrity monitoring sensor, system and method
Inventor: ARTUN LARS
IPC: C23F13/22
Filed: 2020-09-25
Granted: 2022-01-20
Abstract: A sensor (4) for monitoring cathodic protection (CP) levels, i.e. cathodic protection 
potential and current capacity, the sensor being arranged to perform measurements of 
galvanic current and polarized potential between, on one hand, a reference object and, 
on the other hand, one of: i) a sacrificial anode (2) and ii) a protected component (1).  
The sensor comprises a reference electrode (5) in electrical and electrochemical contact 
with a metal sensing element (6) which has a defined surface area (6') exposed to an 
electrolyte, the sensing element electrically coupled to one of the sacrificial anode (2) 
or the protected component (1) via a resistor (15) and a switch (12).  
Figure 1
1/4 
4 - - - - - - - - -, 10 
24 52 1 
15T 16 
3 
Fig.I1
Patent AU-2020244471-B2 (AU)
Title: Power tool with electrically controlled commutating assembly
Inventor: CHUNG FU-HSIANG
IPC: H02P29/00
Filed: 2020-09-30
Granted: 2021-08-12
Abstract: The invention relates to a power tool with an electrically controlled commutating 
assembly comprising: an electrically controlled commutating assembly and a control 
unit; the electrically controlled commutating assembly has an electromagnetic unit; 
5 the electromagnetic unit is capable of performing a change in displacement due to 
electromagnetic action; the control unit has a control member, the control member is 
capable of changing a working direction of a power tool, and displacement of the 
electromagnetic unit is capable of actuating the control member of the control unit to 
make the power tool switch the working direction.  
0
4/19 
511 
30 51 
511 541 
541 54 542 
51 
50 531 52 
20 
542 532 
531 53 
543~5 2 53 7 
5433 
532---_ 20 52153 
521--- -- 421 421 70 
242 
63 
621 
42 60--- -l 
611 
622
40_-- 63 7 
61 541 
Fig. 5 41 
40 
Fig. 6
Patent AU-2020282355-B2 (AU)
Title: A biocompatible membrane composite
Inventor: BRUHN TIMOTHY M
IPC: B01D69/02
Filed: 2020-05-30
Granted: 2023-11-02
Abstract: A biocompatible membrane composite including a first layer (cell impermeable layer), a second layer (a mitigation layer), and a third layer (a vascularization layer) is provided. The mitigation layer may be positioned between the cell impermeable layer and the vascularization layer In some embodiments, the cell impermeable layer and the mitigation layer are intimately bonded to form a composite layer having a tight/open structure. A reinforcing component may optionally be positioned on either side of the biocompatible membrane composite or within the biocompatible membrane composite to provide support to and prevent distortion of the membrane composite. The biocompatible membrane composite may be used in or to form a device for encapsulating biological entities, including, but not limited to, pancreatic lineage type cells such as pancreatic progenitors.
Patent AU-2020289754-B2 (AU)
Title: Low-energy water treatment
Inventor: DUCKWORTH CLIFF ALEXANDER
IPC: C02F1/24
Filed: 2020-09-05
Granted: 2023-11-02
Abstract: An above-ground low-energy method of dewatering highly contaminated waste 
e.g. leachate contaminated with at least a first group of contaminants and PFAS 
is described. The method comprises the step of removing the PFAS before 
removing the first group of contaminants. The removal of PFAS is undertaken by 
actively aerating the contaminated waste comprising PFAS to produce a waste 
stream comprising a concentration of PFAS and a liquid stream having at least 
some of the first group of contaminants. The one or more liquid streams are 
separated from the waste streams so as to dewater the contaminated waste.  
Optionally, the liquid streams are treated to remove the first group of 
contaminants.
6/6 
004 
04 
en m 
raa 
c04 
-oo 
ene 
II~la 
0 -4 
GA 
6 -4 R4
Patent AU-2020289810-B2 (AU)
Title: A circumferential flux electric machine with field weakening mechanisms and methods of use
Inventor: HUNSTABLE FRED E
IPC: H02K3/04
Filed: 2020-12-17
Granted: 2022-06-30
Abstract: OF THE DISCLOSURE 
There are presented various embodiments disclosed in this application, including 
methods and systems of arranging permanent magnets to switch from a first 
configuration designed for a first torque output to a second configuration designed 
for a second torque output.
Patent AU-2020421883-B2 (AU)
Title: Air fryer
Inventor: XU ZHIBO
IPC: A47J37/06
Filed: 2020-09-01
Granted: 2023-12-07
Abstract: An air fryer (1), comprising: a housing (100), in which a cooking cavity (120) and a heating cavity (130) are formed, the heating cavity (130) being located behind the cooking cavity (120); a heating device (102), which is arranged inside the housing (100) so as to heat the cooking cavity (120); and a food container (103), which is placed inside the cooking cavity (120).
Patent AU-2021201111-B2 (AU)
Title: Use of antistatic materials in the airway for thermal aerosol condensation process
Inventor: MYERS DANIEL J
IPC: A61M15/02
Filed: 2021-02-19
Granted: 2022-12-22
Abstract: The disclosure teaches the use of antistatic materials in the airway for thermal 
aerosol generation devices. The present disclosure teaches the use of antistatic materials 
for drug delivery in any drug that may be susceptible to charging during aerosol 
generation.
13 
Figure1I 
BEFOREI NHALAT-IN Thinfilim ofpuredc ru.g 
........ Air-way 
DURING INHALATION Drug Aerosol 
..........  
.. .... . .. .......  
......... .  
....................... .  
..ea....i...gsu....strate.....  
F ig u re2I.. ............ .... .. .. .  
....Airway...eposition....%...ad..d..20.  
d o se )......................  
.. .. .. .. 0.. .... ....  
....... ..0 
...0 .... .. ... ....  
-00 
on M 
0 
a -200 
2' 0 
-400 
10-10 
Standard housing Permastat Permastat Plus
Patent AU-2021257896-B2 (AU)
Title: Steviol glycoside compositions for oral ingestion or use
Inventor: CARLSON TING LIU
IPC: C07H15/256
Filed: 2021-10-25
Granted: 2023-09-21
Abstract: Compositions and uses for steviol glycoside compounds having four glucopyranose residues attached via 
the number 13 carbon (C13) of the steviol moiety and a second group of two or three glucopyranose 
residues attached via the number 19 carbon (C19) of the steviol moiety are described, and exemplified by 
compounds SG101-104. A steviol glycoside composition including one or more of compounds SG101-104 in 
combination with other steviol glycosides including other rebaudiosides can be used as a sweetener 
composition to sweeten other compositions (sweetenable compositions) such as foods, beverages, 
medicines, oral hygiene compositions, pharmaceuticals, nutraceuticals, and the like.
Patent AU-2021269289-B2 (AU)
Title: Tool brownout management
Inventor: GENZ JASON S
IPC: H02M1/36
Filed: 2021-11-15
Granted: 2023-09-07
Abstract: A motorized hand tool, such as a cordless ratchet wrench, that has a motor, one or 
more electronic components and/or integrated circuits, and a step-up converter that are 
housed or disposed in a housing of the tool. The step-up converter is adapted to prevent a 
voltage of a battery of the tool from dropping below a threshold voltage of a component or 
integrated circuit when current draw from the battery increases, thus preventing a "brownout" 
condition.  
18247638_1 (GHMatters) P117722.AU
100 1/5 
LoadCurrent 
VIN 
1 1 0 Step-up Converter 
106 
Power Source VouT/BouT Load 
102 (Motor 104) 
112 Component /IC 
108 
114 
FIG.
2/5 
200 
202 
RECEIVE VOLTAGE (VIN) 
FROM POWER SOURCE 
204 
YESVOUT 2: VBOOST N 
206 
208 
PASS VOLTAGE (VOUT) TO BOOST VOLTAGE (VBOUT): 
COMPONENT / IC VMAX 2 VBOUT VBOOST 
210 
PASS BOOSTED VOLTAGE 
(VBOUT) TO COMPONENT / IC 
FIG. 2
Patent AU-2021330477-B2 (AU)
Title: Camera with infrared module
Inventor: SAMSUDIN IMADI SAFWAN
IPC: G08B13/196
Filed: 2021-08-06
Granted: 2023-04-06
Abstract: A camera (10) includes an optical camera housing (14), and a platform (46) disposed at least partially within the optical camera housing (14). The platform (46) is configured to be pan-rotated about a first axis (30) relative to the optical camera housing (14). The platform (46) includes a first component (50) configured to be coupled to a camera lens (62), and a second component (54) having a mount (58) configured to be fixed to an infrared module (98). The camera (10) also includes a camera lens (62) coupled to the first component (50) of the platform (46). The camera lens (62) is configured to tilt relative to the platform (46) about a second axis (78) different from the first axis (30). The camera (10) also includes an infrared module (98) fixed to the mount (58).
Patent AU-2021343968-B2 (AU)
Title: System and method of printing 3D biostructures
Inventor: RAKSHIT SARBAJIT K
IPC: B29C64/00
Filed: 2021-07-28
Granted: 2023-11-23
Abstract: A computer system (110) for 3D printing a biostructure on an internally damaged area of a patient is provided. The computer system (110) comprises one or more computer processors, one or more computer readable storage media, and computer program instructions. The computer program instructions are stored on the one or more computer readable storage media for execution by the one or more computer processors. The computer program instructions include instructions to: assemble a first bioprinter capsule (120) and a first cartridge capsule (130) to form an assembled bioprinter internally within the patient based, at least in part, on directing one or more external magnetic fields towards a first bioprinter capsule (120) and a first cartridge capsule (130), wherein: the first bioprinter capsule (120) includes a first magnetic signature (124) and at least one interlocking surface (127); and the first cartridge capsule (130) includes a second magnetic signature (134) and at least one interlocking surface (137); move the assembled bioprinter to the internally damaged area of the patient based, at least in part, on altering the one or more external magnetic fields directed towards the assembled bioprinter; and print, via the assembled bioprinter, a first biostructure onto the internally damaged area of the patient based, at least in part, on altering the one or more external magnetic fields directed towards the assembled bioprinter, wherein the one or more external magnetic fields are sequentially altered to incrementally move the assembled bioprinter along at least one plane．
Patent AU-2022202628-B2 (AU)
Title: Quantitation of tamoxifen and metabolites thereof by mass spectrometry
Inventor: CLARKE NIGEL
IPC: A61K31/135
Filed: 2022-04-20
Granted: 2023-06-08
Abstract: QUANTITATION OF TAMOXIFEN AND METABOLITES THEREOF BY 
MASS SPECTROMETRY 
ABSTRACT 
Provided are methods for determining the amount of tamoxifen and its metabolites in a sample 
by mass spectrometry. In some aspects, the methods provided herein comprise determining the 
amount of norendoxifen. In some aspects, the methods provided herein comprise determining the 
amount of norendoxifen and tamoxifen. In some aspects, the methods provided herein comprise 
determining the amount of norendoxifen and other tamoxifen metabolites. In some aspects, the 
methods provided herein comprise determining the amount of tamoxifen, norendoxifen, and 
other tamoxifen metabolites.
Patent AU-2022211908-B2 (AU)
Title: Subcutaneous administration of adamts13
Inventor: KOPIC ALEXANDRA NATHALIE
IPC: A61K38/48
Filed: 2022-08-05
Granted: 2023-11-30
Abstract: EDITORIAL NOTE 
APPLICATION NUMBER - 2022211908 
Please note: Abstract page 38 should be numbered 39.
ABSTRACT 
This invention relates to methods of subcutaneous administration of ADAMTS13 
formulations to a treat a disease or condition associated with ADAMTS13 and VWF 
dysfunction. Furthermore, evidence of the unexpectedly high bioavailability of ADAMTS13 
formulations administered subcutaneously is provided herein.  
38
Patent JP-3658271-B2 (JP)
IPC: B32B7/022
Filed: 2000-03-31
Granted: 2005-06-08
Abstract: This invention aims to provide a composite sheet having a layer of inelastically stretchable continuous fibers improved so that a possible unevenness in fiber diameter may be minimized. A composite sheet 10 comprises an elastically stretchable layer 3 and an inelastically stretchable layer 2 formed with inelastically stretchable continuous fibers 6 bonded to at least one surface of the elastically stretchable layer 2 intermittently in one direction. The continuous fibers 6 are oriented substantially in one direction thereof so that the composite sheet 10 may present a ratio S1/S2 of 3.0 or higher where S3 represents a tensile strength in this one direction and S2 represents a tensile strength in the direction orthogonal to this one direction. <IMAGE>
Patent JP-3801865-B2 (JP)
IPC: C12Q1/6848
Filed: 1998-08-06
Granted: 2006-07-26
Abstract: The present invention provides a method of removing nucleic acid contamination in an amplification reaction which comprises use of a thermolabile DNase and a method of preventing or reducing false positive results due to carry-over in a nucleic acid amplification reaction, said method comprising using a thermolabile DNase to degrade carried-over non-target double-stranded DNA present in the amplification reaction mixture. A thermolabile DNase from the shrimp Pandalus borealis has been identified which is suitable for use in the methods of the invention.
Patent JP-4741726-B2 (JP)
IPC: A61P31/04
Filed: 1999-05-27
Granted: 2011-08-10
Abstract: Use of an anti-inflammatory agent such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the lower respiratory tract which are susceptible to the administration of such agents.
Patent JP-4343438-B2 (JP)
IPC: A61N2/02
Filed: 1999-06-12
Granted: 2009-10-14
Abstract: An apparatus for treatment of a portion of a biological body with magnetic fields having a device adapted for producing spin resonances for treatment within a portion of the biological body to be treated. The apparatus includes a magnet for producing a magnetic field, a coil system for producing a magnetic alternating field at right angles to the magnetic field, control electronics for actuation of the magnet and the coil system adapted to produce nuclear spin resonance in at least a portion of a biological body, and a device for repeated actuation of the control electronics to produce a defined sequence of nuclear spin resonances. The sequence of nuclear spin resonances produced by the device is determined by the spin-lattice relaxation time T1of at least one portion of the biological body, and has a repetition rate of approximately 3T1.
Patent JP-4729177-B2 (JP)
IPC: G06M3/02
Filed: 2000-02-10
Granted: 2011-07-20
Abstract: Methods and apparatus for controlling air supplied under pressure to a patient suffering from sleep disorders such as apnoea. Controlled pressurized air is supplied to the patient's upper anatomical airways by the apparatus according to the methods of the present invention. The apparatus measures the air flow and pressure to the airway, and determines whether to increase or decrease the pressure based on a determination of several factors, such as the occurrence of an obstructive or central apnoea, hyperventilation, air leakage and acoustical vibrations. Occurrences of apnoeas may be stored by the apparatus and read by a clinician at a later date.